NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Sanofi said on Wednesday a first late-stage Phase III study of its LixiLan diabetes drug had met its main target, while another would be completed at the end of the third quarter. LixiLan consists of a single-injection combination of Lyxumia, a drug developed with Danish drugmaker Zealand Pharma , and…

news

India may contest a decision by the European drug regulator to recommend a ban on as many as 700 generic products tested by GVK Biosciences at its Hyderabad facility, citing it as a restriction on trade. The decision, which was reiterated by the European Medicines Agency last week, will become…

news

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has entered into a definitive agreement under which it will sell its global contrast media and delivery systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in a transaction valued at approximately $270 million. Mallinckrodt's action to divest its CMDS…

news

City-based Aurobindo Pharma Limited today said it has received final approvals from the US Food and Drug Administration (USFDA) to manufacture and market Esmolol Hydrochloride Injection. According to a press release, Esmolol Hydrochloride Injection, 100mg/10mL (10mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Brevibloc Injection,…

news

Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee. The independent panel of scientific advisors made its recommendation after taking an interim…

news

Bellerophon Therapeutics Inc's shares plummeted more than 60 percent on Monday after the company said an injectable heart drug it is developing under license failed in a study. The drug, bioabsorbable cardiac matrix, was licensed from BioLineRx Ltd in 2009 after animal studies showed that it acted as a "scaffold"…

news

Allergan PLC, amid reports that it is looking to separate its hefty generic drug business in a different $45 billion deal, said Sunday that it has agreed to buy for $560 million cash upfront a privately held developer of treatments for depression. Allergan’s deal for Naurex Inc., based in Illinois,…

news

JPMorgan will bankroll Lupin for its $880 million acquisition of Gavis, a New Jersey-based generic drug firm. The Wall Street bank will act as guarantor till the date of payment, which is some weeks away, and then lend the full deal amount that Lupin will have to repay over a…

news

The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences. The largest EU-wide suspension of sales and distribution of generic drugs ordered by the European Commission will come into effect on August 21 and…

news

The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA (SASY.PA) and Regeneron Pharmaceuticals Inc (REGN.O) on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease. The FDA ruling came just hours after European…